Clinical Trial Update: Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial on long-term safety and tolerability of idalopirdine (Lu AE58054) as add-on to donepezil in mild-to-moderate Alzheimer's disease; complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)
• Idalopirdine (idalopirdine)
• Lu AE58054

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-08-10